GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Articles / IHMT / NOVA participates in a Science Advances study that reveals the global spread of tuberculosis and its relation to European expansion and development of antibiotic resistance.

IHMT / NOVA participates in a Science Advances study that reveals the global spread of tuberculosis and its relation to European expansion and development of antibiotic resistance.

October 19, 2018


IHMT / NOVA participates in the most complete genomic analysis carried out on the most widespread form of the Tuberculosis bacillus, called Lineage 4 and predominant in Portugal and Europe, significantly increasing our understanding of the origin and dissemination of the most common and most tuberculosis, as well as their appetite for drug resistance. This study was published this week in the journal Science Advances.

For the study, genomic sequences of 1,669 Line 4 samples from different points in time were analyzed in Europe, Africa, Southeast Asia, South America and North America. These include samples taken from mummies from hundreds of years to today. Previous studies have shown that the ancestor of all TB strains evolved in Africa 4,000-6000 years ago and spread out from the mainland to the rest of the world. Of the seven current strains of the Tuberculosis bacillus, only lineages 2 and 4 are truly global in their distribution, reflecting a combination of past human migrations and their more effective transmission in relation to other strains. Lineage 4 in particular emerged in Europe some 1,000 years before it became the globally dominant form of tuberculosis globally. They are highly adapted to accuse active disease in humans but it has been shown that resistance to antibiotics is a recent and local problem, now present in several countries and regions, but with a minimal dispersion between countries as a result of bad health practices and lack of adherence to therapy by patients. Thus, countries that are able to stop the transmission of resistant strains within their territory should expect a massive reduction in drug-resistant tuberculosis – as was the case in Portugal.

To read the article please click here.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

Trackbacks

  1. go to Cesteh Ensp Fiocruz says:
    2022-02-14 at 00:06

    go to Cesteh Ensp Fiocruz

    IHMT / NOVA participates in a Science Advances study that reveals the global spread of tuberculosis and its relation to European expansion and development of antibiotic resistance. – GHTM

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

 

Loading Comments...
 

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok